The forms of urologic pathology and their treatment in Parkinson's disease
Krivoborodov, G.G.; Gekht, A.B.; Korshunova, E.S.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 107(4): 68-72
2007
ISSN/ISBN: 1997-7298 PMID: 18683343 Document Number: 611852
Document emailed within 1 workday
Related Documents
Goulley, F.; Wolmark, Y.; Bourdeix, I.; Chaumet-Riffaud, P.D. 1993: Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms Therapie 48(3): 233-238Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1996: New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease Journal of Neural Transmission. Supplementum 48: 1-6
Kidron, D.; Melamed, E. 1987: Forms of dystonia in patients with Parkinson's disease Neurology 37(6): 1009-1011
Vendrova, M.I.; Sadekov, R.A.; Golubev, V.L. 2000: Efficiency of new forms of madopar in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(12): 46-48
Jellinger, K. 1990: New developments in the pathology of Parkinson's disease Advances in Neurology 53: 1-16
García Novio, F.; Moreda Pérez, M.; Mateo Cambón, L.; Asorey Fernández, A.; Rico Morales, M.; Romero García, U. 1991: Use of the urologic resectoscope in the treatment of rectal pathology. Analysis of our experience and review of the literature Archivos Espanoles de Urologia 44(1): 65-68
Simonidze, V.; Samushia, O.; Gogsadze, M. 2018: Analysis of Cognitive Disorders with different Clinical Forms of Parkinson's Disease Georgian Medical News 2018(280-281): 61-63
Brice, A. 1998: Parkinson disease: monogenic forms and genetic susceptibility factors Pathologie-Biologie 46(9): 710-712
Broussolle, E.; Defuentes, G.; Plauchu, H.; Chazot, G. 1997: Incidence and clinical profile of familial forms of Parkinson's disease. A study of 428 index-cases from a department of neurology Revue Neurologique (Paris) 153(6-7): 406-411
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
de Fromont, M.; Lesourd, Aès.; Mazerolles, C.; Molinié, V.; Voigt, J-Jacques.; Fromont, Gëlle.; Soulié, M.; Mottet, N.; Irani, J.; Méjean, A.; Rebillard, X.; Davin, J-Louis. 2007: Standardized calculation in the pathology of urologic cancers Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(6): 1026
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Rabasseda, X. 1999: Perspectives in the treatment of Parkinson's disease: COMT inhibitors open up new treatment strategies Drugs of Today 35(9): 701-717
Vijayaraghavan, A.; Radhakrishnan, K. 1995: Treatment of Parkinson's disease Neurology India 43(2): 77-82
Vijayaraghavan, A.; Radhakrishnan, K. 1996: Treatment of Parkinson's disease Neurology India 44(4): 177-182
Jameson, H.D. 1972: Treatment of Parkinson's disease Journal of the Kentucky Medical Association 70(4): 304-307